You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

PRIMIDONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Primidone patents expire, and what generic alternatives are available?

Primidone is a drug marketed by Amneal Pharm, Anda Repository, Carnegie, Dr Reddys Labs Ltd, Hikma Intl Pharms, Impax Labs, Lannett, Oxford Pharms, Rubicon, and Watson Labs. and is included in eleven NDAs.

The generic ingredient in PRIMIDONE is primidone. There are seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the primidone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Primidone

A generic version of PRIMIDONE was approved as primidone by WATSON LABS on December 31st, 1969.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PRIMIDONE?
  • What are the global sales for PRIMIDONE?
  • What is Average Wholesale Price for PRIMIDONE?
Drug patent expirations by year for PRIMIDONE
Drug Prices for PRIMIDONE

See drug prices for PRIMIDONE

Drug Sales Revenue Trends for PRIMIDONE

See drug sales revenues for PRIMIDONE

Recent Clinical Trials for PRIMIDONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Simbec OrionPhase 2
KABS laboratoriesPhase 2
Dr. Jurjan AmanPhase 2

See all PRIMIDONE clinical trials

Pharmacology for PRIMIDONE
Medical Subject Heading (MeSH) Categories for PRIMIDONE
Anatomical Therapeutic Chemical (ATC) Classes for PRIMIDONE

US Patents and Regulatory Information for PRIMIDONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharm PRIMIDONE primidone TABLET;ORAL 040866-001 Apr 23, 2008 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rubicon PRIMIDONE primidone TABLET;ORAL 214896-003 Dec 28, 2022 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dr Reddys Labs Ltd PRIMIDONE primidone TABLET;ORAL 040862-001 Oct 3, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.